CPI - Adjustment Factors (Actual) - 2012
Preliminary Price-Adjustment Factors (Based on Forecast Inflation Rates)
Table 1 reproduces preliminary price-adjustment factors for 2012 published in the April 2011 NEWSletter. These factors were based on forecasted annual CPI-inflation rates of 2.4% and 2.1% for 2011 and 2012, respectively.
Table 1 Preliminary 2012 Price-Adjustment Factors for Patented Drug Products (Based on Forecast CPI-Inflation Rates for 2011 and 2012)
Benchmark Year |
(1) 2009 |
(2) 2010 |
(3) 2011 |
Price-Adjustment Factor |
1.064 |
1.046 |
1.021 |
These figures imply: (1) a maximum allowable cumulative price increase between 2009 and 2012 of 6.4% for patented drug products with Canadian sales in 2009 (that is, products whose “benchmark year” is 2009); (2) a maximum allowable cumulative price increase between 2010 and 2012 of 4.6% for products whose first Canadian sales occurred in 2010; and (3) a maximum allowable cumulative price increase between 2011 and 2012 of 2.1% for products whose first Canadian sales occurred in 2011.
In addition, the forecast inflation rate of 2.1% for 2012 implies a year-over-year price increase cap (applicable to all drug products, regardless of benchmark year) of 3.2% (= 1.5 x 2.1%) for 2012.
Final Price-Adjustment Factors (Based on Actual Inflation Rates)
The actual rate of CPI inflation for 2011 of 2.9% was published in the January 2012 NEWSletter. The actual rate of CPI inflation for 2012 is now available and was 1.5%. These rates (along with the actual 2010 CPI-inflation rate of 1.8%) yield the following final price-adjustment factors.
Table 2 Final 2012 Price-Adjustment Factors for Patented Drug Products (Based on Actual CPI-Inflation Rates for 2011 and 2012)
Benchmark Year |
(1) 2009 |
(2) 2010 |
(3) 2011 |
Price-Adjustment Factor |
1.063 |
1.045 |
1.015 |
The final year-over-year price increase cap for 2012 is 2.3% (= 1.5 x 1.5%).